TCL Archive Nixon Resignation Won’t Hurt Cancer Program, Might Lead To More Money; Weinberger Stays August 16, 1974
TCL Archive New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor. February 24, 2006
TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010